Core Insights - The "Summer Research Study: Exploring Beijing" tourism promotion event has launched 10 themed research study travel routes aimed at enhancing summer tourism experiences for students [1][2] - Over 120 cultural and tourism venues across 16 districts in Beijing are offering exclusive discounts and packages for students, including reduced ticket prices and special offers [2][3] - The initiative aims to provide immersive and thematic educational travel products, allowing students to learn through exploration and experience [1][2] Group 1: Themed Travel Routes - The 10 themed travel routes include various educational themes such as geological exploration, insect observation, stargazing, and industrial research, with nearly 40 points of interest [1][4] - Specific routes include: 1. Science and Technology Practice Enlightenment Line 2. Cave and Ancient Human Geological Archaeology Line 3. Natural Mysteries and Ancient Village Exploration Line 4. Brilliant Light and Color Art Appreciation Line 5. "Going to Beijing for Exams" Red Footprint Pursuit Line 6. Traditional Opera and Intangible Cultural Heritage Experience Line 7. Grand Canal Culture and Sub-center Development Perception Line 8. "Two Parks and One River" and Western Beijing Ancient Road Exploration Line 9. Great Wall Stargazing and Star Town Exploration Line 10. Paleontology and Geological Science Knowledge Line [4][5] Group 2: Discounts and Offers - Various cultural and tourism venues are providing special summer research study packages, with ticket prices as low as 55 yuan for students and special discounts for exam candidates [2] - Notable offers include discounted tickets for exhibitions and unique experiences at locations such as the Beijing Science Center and the AI Magic Laboratory [2][3] Group 3: Market Adaptation - The Beijing Municipal Bureau of Culture and Tourism is adapting to market demands by optimizing summer tourism experiences, positioning Beijing as a popular destination for educational travel [3]

图为Zi.Care的创始人Jessy Abdurrahman在做项目讲演 本报（chinatimes.net.cn）记者陶炜 苏州摄影报道 "我们希望把中国的科技带到印尼去。"印尼领先的健康科技公司Zi.Care的创始人Jessy Abdurrahman对 《华夏时报》记者说。 他们借参赛寻找合作者 据了解，Zi.Care是一家领先的健康科技公司，向印尼的医院、诊所和医疗从业者提供全国唯一达到第 七级标准的AI驱动电子病历系统。公司已累计处理超过800万份患者记录，凭借强有力的政府支持和 130多家医疗机构的广泛采用，Zi.Care正在扩展其物联网医疗（IoMT）解决方案业务。在他的项目讲演 过程中，他多次强调自身在印尼有非常强的政府关系。 "目前我们的愿景是做一个一站式的医疗健康平台，我们想要整合一些中国的科技，把这些中国的科技 带到印尼市场去。因为印尼目前很多的产品硬件都是被美国欧洲垄断的，这些产品的价格比较贵，而中 国的产品相对来说是性价比更高的，同样的性能价格往往更低。"Jessy Abdurrahman对《华夏时报》记 者说。他表示，在印尼的铁路行业和矿产行业都有中国企业参与，他希望在他所处的领域也 ...

Group 1 - The core viewpoint of the news is the official release of the "Beijing Action Plan for Accelerating AI Empowerment in Scientific Research for High-Quality Development (2025-2027)", marking a strategic roadmap for AI for Science in Beijing and the first local policy in China focused on this area [1] - AI for Science is recognized globally as a new paradigm to accelerate scientific research, with Beijing positioning itself as a leader in this field by establishing the Beijing Academy of Scientific Intelligence in 2021 [2][6] - The Action Plan aims to integrate AI with scientific research, focusing on breakthroughs in fundamental theories and interdisciplinary collaboration, with goals to build at least 10 high-quality scientific databases and serve over 10 million users by 2027 [3] Group 2 - The Beijing Municipal Development and Reform Commission plans to enhance the overall planning and systematic layout of scientific intelligence, targeting key disciplines such as materials and life sciences to develop specialized models [4] - The Beijing Economic and Information Technology Bureau emphasizes the importance of AI in accelerating scientific innovation across various sectors, including biomedicine and new materials, while acknowledging existing challenges in the industrial application of scientific intelligence [5] - The Haidian District aims to strengthen the foundation for scientific intelligence development by supporting advanced research elements and creating a comprehensive support system for scientific innovation [6] Group 3 - Significant achievements in the field of AI for Science include the "Bohler Research Space Station," which integrates literature review, computation, and experimentation, currently utilized by over 900,000 users across more than 40 universities and companies [7] - The "DPA Large Atom Model," developed by over 30 organizations, aims to enhance the understanding of atomic interactions, achieving world-leading stability and predictive performance while reducing data computation costs by 90% [8] - The "Uni-Lab-OS" intelligent laboratory operating system transforms traditional labs into autonomous "AI scientists," improving efficiency and data sharing among instruments [9] - The "DeepFlame" software enables comprehensive numerical simulations of rocket engines, significantly reducing development costs and time by allowing for virtual testing of extreme conditions [10]

智通财经记者 | 黄华 图片来 源于文章截图 智通财经编辑 | 谢欣 儿童铅中毒再度成为国内被普遍关注的公共卫生问题。 据国内中高端私立医疗机构卓正医疗旗下卓正科普公众号7月10日文章显示，2019年全球疾病负担数据 显示，中国儿童血铅水平超过50µg/L的人数估计为3123.77万人。当年，中国0-14岁人口是2.37亿人。 50μg/L是2021年世界卫生组织（WHO）《铅暴露临床管理指南》中提出的人体铅水平临界数据，该文 件建议，只要血铅水平超过该值，就有必要采取干预措施。 卓正科普前述文章还显示，国内有35.1%的孩子血铅高于50μg/L；在不同地区方面，贵州和黑龙江大部 分儿童血铅水平在50-100μg/L，云南省有超60%的儿童血铅水平高于100μg/L；也有很多地区，儿童血 铅的统计调查数据至今缺失。 针对地区差异问题，据《中华流行病学杂志》2002年6月第23卷第3期中曾发布《中国城市儿童血铅水平 调查》一文指出，兰州市、海口市、洛阳市、新乡市、郑州市的儿童血铅超过100μg/L比例均大于 50%，这些地区儿童铅中毒不容忽视（如下图）。 根据卫生部2006年发的《血铅临床检验技术规范》，用于儿 ...

Meta Platforms(META.O)：在英国剑桥新建价值1600万美元的音频研究实验室。 ...

Core Insights - Company is addressing investor concerns regarding its competitive gaps in the chemiluminescence sector compared to overseas giants and strategies to close these gaps [1] - The company has gained recognition in the domestic market for its infectious disease and tumor marker packages, and plans to launch a new generation of hormone packages by 2025 [1] - The company is enhancing its localization capabilities overseas, particularly after acquiring DiaSys, which has improved brand recognition and customer trust in Europe [1] Group 1 - The company's in vitro diagnostic segment is performing exceptionally well, with a projected revenue growth of 10.8% year-on-year in 2024, surpassing its life information and support business for the first time [2] - The international in vitro diagnostic business has seen over 30% year-on-year growth, with the domestic chemiluminescence business ranking third in the market for the first time [2] - The company has successfully penetrated 115 overseas third-party laboratory chains and installed two MT8000 full laboratory automation lines, with expectations for further growth in 2025 [2] Group 2 - The company is committed to establishing local operations and teams in Europe and developing countries to strengthen its overseas presence [1] - The heart marker and hormone package projects have received widespread recognition from European and American experts, indicating potential for clinical academic collaborations [1] - The company aims to catch up with imported brands in five core chemiluminescence packages and achieve superior performance in certain projects [1]

Core Viewpoint - The company is focusing on identifying its shortcomings in product development and sales as it expands its digital and streamlined business, considering both internal growth and potential acquisitions to address these gaps [1][2]. Group 1: Product Development - The company has enhanced its research capabilities in information technology and high-consumption areas through self-built teams and investments, reducing the urgency for external demands [1]. - Future needs in new or niche areas may require external acquisitions to strengthen capabilities [1]. Group 2: Sales Strategy - The company recognizes the need to improve its solution marketing capabilities, which differ from simple equipment sales and require tailored solutions based on customer needs and information technology levels [2]. - There are existing gaps in local delivery and sales channels for high-value consumables in overseas markets, prompting the company to consider both internal development and acquisitions, such as the acquisition of DiaSys for its global production and logistics capabilities [2]. Group 3: Business Growth and AI Integration - The company's IVD (in vitro diagnostics) business is projected to be a key growth driver, with expected revenue of 13.765 billion yuan in 2024, marking it as the largest business segment [2]. - The company has successfully penetrated international markets, achieving over 30% year-on-year growth in international IVD revenue [2]. - AI technology is being integrated across the company's three main business lines, enhancing product performance and market competitiveness, with notable innovations such as the clinical application of AI models and comprehensive solutions in medical imaging [3].

杰西卡 发自 凹非寺 量子位 | 公众号 QbitAI 港股等来一位105亿的机器人独角兽。 镁伽科技，据称是中国收入最高的机器人自主智能体供应商，近期向港交所递交了招股书。 创始团队来自电子制造巨头和华为，创业初衷，是要做出真正能"解放科学家"的机器人。生命科学和制造行业，你都能听到它的名字。 背后不仅有 博世、药明康德 两大巨头力挺，还有 高盛、创新工场、经纬创投 等明星资本加持，估值已超105亿元。 如今机器人赛道如火如荼，镁伽科技也走到了自己的IPO时刻。 CEO黄瑜清曾透露过选择这一领域的原因： 我们发现，不同于自动化发展非常成熟的汽车、半导体行业， 生命科学 领域实验的方法，和100年前几乎没有太大区别。从业人员还是 要把80%以上的时间用在基础工作上。 而镁伽的初心，就是向客户交付一个"机器人科学家"——由机器人完成实验室的基础工作，让科学家有更多时间去设计实验和分析数据。 因此，镁伽在这方面的核心智能体产品，可以实现生命科学及实验室场景中的各类需求，例如液体处理、饮品分液、高内涵细胞成像分析、全 流程自动化制药等等。 镁伽科技是谁？ 成立于2016年的 镁伽科技 ，是一家机器人技术领域的自主智 ...

以下文章来源于东四十条资本 ，作者鲁智高 东四十条资本 . 聚焦股权投资行业人物、事件、数据、研究、政策解读，提供专业视角和深度洞见 | 创投圈有趣的灵魂 将投中网设为"星标⭐"，第一时间收获最新推送 85后潮汕人带队。 作者丨 鲁智高 来源丨 东四十条资本 从北京起步，到扎根苏州和杭州，一家融到D轮的明星独角兽于近日冲向港股。 在专注于机器人自动化与AI的过程中，镁伽科技打造出覆盖生命科学、化工、餐饮、农业、集成电路、新能源等领域的一系列 自主智能体，并在服务安捷伦科技、药明康德、金域医学、瑞幸咖啡等客户中，一年的收入接近10亿元。 一路走来，从高盛、臻云创投、英诺天使基金、Granite Asia、创新工场、亚投资本、愉悦资本、明势创投、博世创投、戈壁 创投、经纬创投、药明康德、中金资本、苏州国发创投、义翘神州、园丰资本、泰合资本、新加坡蘭亭投资等手中拿到超27亿 元后，这家公司的估值达到105亿元。 85后潮汕人带队，干出一家明星独角兽 镁伽科技的故事，得从三位共事多年的好友讲起。 从西安交通大学毕业后，学习通信和自动化的黄瑜清于2009年进入普源精电工作。那个时候，分别毕业于北京交通大学和西 安电子科 ...

以"智慧互联、精准高效"为核心定位，该智慧实验室实现了检验全流程的系统性革新。在样本传输环节，实验室采用先进的气动传输技 术，打造随采随传的物流网络，传输速度达600份/小时，仅需5秒即可将样本从门诊采血区直达检测仪器区，显著降低了人工操作强度与 差错风险。 在样本处理环节，自动化流水线借助智能识别样本唯一标识，实现了住院标本和体检标本的"一次性倾倒"。检验人员无需逐份整理，只 需将批量样本放置于进样区，系统便会自动完成分类分流，做到"同类样本集中处理"；配合智能轨道系统，样本能够被精准输送至对应 检测设备，真正实现"一管样本、多项目联动检测"。检测完成后，样本自动转入后处理冰箱，按预设规则智能分类归档，到期后自动清 理，全程可追溯。 齐鲁晚报.齐鲁壹点褚思雨通讯员许丹丹邹亦轩 6月30日，邹城市人民医院医学检验科"智慧实验室"顺利完成交付验收。作为山东省县市级医疗机构中首家智慧实验室，该项目的落地不 仅标志着邹城市医学检验服务正式迈入智能化、高效化新阶段，更成为医院智慧化建设进程中的关键里程碑。 全流程自动化 构建"无人化"检验闭环 依托"自动化系统+信息化技术"双轮驱动，实验室通过先进的MALAB中间体软 ...